SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-324372
Filing Date
2013-08-07
Accepted
2013-08-07 16:46:20
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d550990d10q.htm 10-Q 800087
2 EX-10.3 d550990dex103.htm EX-10.3 132050
3 EX-31.1 d550990dex311.htm EX-31.1 6590
4 EX-31.2 d550990dex312.htm EX-31.2 6586
5 EX-32.1 d550990dex321.htm EX-32.1 3492
6 EX-32.2 d550990dex322.htm EX-32.2 3488
  Complete submission text file 0001193125-13-324372.txt   8268595

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tsrx-20130630.xml EX-101.INS 832163
8 XBRL TAXONOMY EXTENSION SCHEMA tsrx-20130630.xsd EX-101.SCH 51168
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tsrx-20130630_cal.xml EX-101.CAL 50392
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tsrx-20130630_def.xml EX-101.DEF 176366
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsrx-20130630_lab.xml EX-101.LAB 375860
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsrx-20130630_pre.xml EX-101.PRE 286414
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34828 | Film No.: 131018222
SIC: 2834 Pharmaceutical Preparations